European Gram Negative AntiBacterial Engine

ENABLE Management

The whole consortium is managed by a Consortium Management Office and especifically:

Project coordinator

  • Neil Pearson, GlaxoSmithKline Research and Development Ltd (

Managing entity

  • Anders Karlén, Uppsala University (

ENABLE is a European-based consortium:


The ENABLE project has created and is currently managing a drug discovery platform. 
This platform consists of dedicated teams who pool their resources for the testing and optimization of molecules.

Resource allocation to programmes is managed by the Implementation Committee.

The Consortium Management Office supports all above governing and is responsible for the overall project management as well as communication with the Innovative Medicines Initiatives office.

The Portfolio Management Committee (PMC) is the body in charge of ensuring the prosperity of ENABLE portfolio. 
It is responsible for reviewing and approving the entry of new programmes into the portfolio. 
To learn more one the Open Call Process, please click here.

In addition the PMC determines quarterly whether programmes may continue activity in ENABLE and when to proceed to the successive development steps

To learn more about our portfolio, please click here.

With any queries regarding the ENABLE project, please contact the Dissemination Manager: 

Clément Robijns
Tel: 0049 (0)30-264 921-58

The research leading to these results has received support from the Innovative Medicine Initiative Joint Undertaking under grant agreement no 115583, resources of which are composed of financial contributions from the European Union`s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies` in kind contribution.